Improved Recombinant Human Follicle-Stimulating Hormone

Patent No. EP3075744 (titled "Improved Recombinant Human Follicle-Stimulating Hormone") was filed by Glycotope on Aug 4, 2011. The application was issued on Dec 18, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AUGUST DEBOUZYSep 11, 2020AUGUST DEBOUZY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3075744

GLYCOTOPE
Application Number
EP16168841A
Filing Date
Aug 4, 2011
Status
Revoked
Aug 6, 2021
Publication Date
Dec 18, 2019